Literature DB >> 1392427

Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients.

D Wagner1, I Wagenbreth, R Stachan-Kunstyr, J Flik.   

Abstract

Some 86 heart transplant recipients under immunosuppressive therapy were vaccinated against hepatitis B using the vaccine Gen H-B-Vax-D, but 95.3% failed to develop protective levels of HBs-specific antibody (more than 10 U/l) after the third vaccination.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1392427     DOI： 10.1007/bf00184798

Source DB:  PubMed          Journal:  Clin Investig        ISSN： 0941-0198


  8 in total

1.  Immunogenicity of recombinant hepatitis B vaccine in dialysis patients.

Authors:  W Jilg; M Schmidt; B Weinel; T Küttler; H Brass; J Bommer; R Müller; B Schulte; A Schwarzbeck; F Deinhardt
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

2.  Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients.

Authors:  J Crosnier; P Jungers; A M Couroucé; A Laplanche; E Benhamou; F Degos; B Lacour; P Prunet; Y Cerisier; P Guesry
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

3.  Hepatitis B vaccine: randomized trial of immunogenicity in hemodialysis patients.

Authors:  E Benhamou; A M Courouce; P Jungers; A Laplanche; F Degos; J Brangier; J Crosnier
Journal:  Clin Nephrol       Date:  1984-03       Impact factor: 0.975

4.  Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination.

Authors:  S C Meuer; H Dumann; K H Meyer zum Büschenfelde; H Köhler
Journal:  Lancet       Date:  1989-01-07       Impact factor: 79.321

5.  Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.

Authors:  C E Stevens; H J Alter; P E Taylor; E A Zang; E J Harley; W Szmuness
Journal:  N Engl J Med       Date:  1984-08-23       Impact factor: 91.245

6.  Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial.

Authors:  J Desmyter; J Colaert; G De Groote; M Reynders; E E Reerink-Brongers; P N Lelie; P J Dees; H W Reesink
Journal:  Lancet       Date:  1983-12-10       Impact factor: 79.321

7.  Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients.

Authors:  P J Grob; U Binswanger; K Zaruba; H I Joller-Jemelka; M Schmid; W Häcki; A Blumberg; A Abplanalp; W Herwig; H Iselin; C Descoeudres
Journal:  Antiviral Res       Date:  1983-03       Impact factor: 5.970

8.  [Evaluation of the efficacy of a recombinant hepatitis B vaccine].

Authors:  S Polywka; S Gatermann; H von Wulffen; R Laufs
Journal:  Immun Infekt       Date:  1988-10
  8 in total
  4 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

2.  Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3 containing pre-S1, pre-S2, and S gene products.

Authors:  D Wagner; I Wagenbreth; R Stachan-Kunstyr; H A Thoma; A E Hemmerling; J Flik
Journal:  Clin Investig       Date:  1994-05

Review 3.  Efficacy of the vaccination in inflammatory bowel disease.

Authors:  Elisa Carrera; Rebeca Manzano; Elena Garrido
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

Review 4.  Serologic vaccination response after solid organ transplantation: a systematic review.

Authors:  Isabella Eckerle; Kerstin Daniela Rosenberger; Marcel Zwahlen; Thomas Junghanss
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.